Latest Views & News

Marmite King Versus the Panadol Prince. There Could Be Money to be Made here, Gang

By Malcolm Stacey | Monday 17 January 2022

Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Hello Share Shovers. You’ll either love this possible takeover – or hate it. The owner of Marmite is rumoured to very much want to snaffle the giant consumer arm of GlaxoSmithKline (GSK). And Unilever (ULVR) actually made a £50 billion approach. This was turned down as being too low. As an owner of GSK shares, I agree that it wasn’t an enticing proposition and I expect a bigger one to come.

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

That Was the Week that Was